Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy

Clinical implications of gene discovery in Parkinson's disease and parkinsonism

(2010) Christian Wider et al.   MOVEMENT DISORDERS

Plasma α-synuclein in patients with Parkinson's disease with and without treatment

(2010) Raquel Duran et al.   MOVEMENT DISORDERS

Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease

(2010) Kelvin K. Leung et al.   NEUROIMAGE

Alzheimer’s disease: diagnostics, prognostics and the road to prevention

(2010) Iris Grossman et al.   EPMA Journal

Advances in the genetics of Parkinson's disease

(2009) Serena Rosner et al.   ACTA PHARMACOLOGICA SINICA

Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease

(2009) Alberto Ascherio   ARCHIVES OF NEUROLOGY

A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson’s disease

(2009) Katia Varani et al.   FASEB JOURNAL

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

(2009) Pieter Jelle Visser et al.   LANCET NEUROLOGY

Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging

(2009) Dean M. Connor et al.   NEUROIMAGE

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease

(2009) A D Roses et al.   PHARMACOGENOMICS JOURNAL

Clinical proteomics in neurodegenerative disorders

(2008) H. Zetterberg et al.   ACTA NEUROLOGICA SCANDINAVICA

The amyloid cascade hypothesis

(2008) Amos D. Korczyn   Alzheimers & Dementia

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B

(2008) Ville Leinonen   ARCHIVES OF NEUROLOGY

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease

(2008) Michael A. Schwarzschild   ARCHIVES OF NEUROLOGY

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

(2008) M. Bogdanov et al.   BRAIN

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Blood-based proteomics for personalized medicine: examples from neurodegenerative disease

(2008) Ira L Goldknopf   Expert Review of Proteomics

Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies

(2008) Constantine G. Lyketsos et al.   INTERNATIONAL PSYCHOGERIATRICS

REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features

(2008) R B Postuma et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

(2008) Lars Bertram et al.   NATURE REVIEWS NEUROSCIENCE

Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease

(2008) Daniela Berg   Neurodegenerative Diseases

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

(2008) Robin Barbour et al.   Neurodegenerative Diseases

Toward a plasma marker for Alzheimer disease: Some progress, but still a long way to go

(2008) H. A. Crystal et al.   NEUROLOGY

Biochemical markers in persons with preclinical familial Alzheimer disease

(2008) J. M. Ringman et al.   NEUROLOGY

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

(2008) Alexander I. Tröster   NEUROPSYCHOLOGY REVIEW

GATA transcription factors directly regulate the Parkinson's disease-linked gene  -synuclein

(2008) C. R. Scherzer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Technology Insight: imaging neurodegeneration in Parkinson's disease

(2008) David J Brooks   Nature clinical practice. Neurology

Secretion of DJ-1 into the serum of patients with Parkinson's disease

(2007) Chinatsu Maita et al.   NEUROSCIENCE LETTERS